Mono Pharmacare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Income	-	-	9.44	3.51	0.95	0.2
Depreciation & Amortization	-	-	0.51	1.08	1.28	1.05
Other Operating Activities	-	-	13.05	8.66	7.05	3.14
Change in Accounts Receivable	-	-	-122.87	-1.74	-20.24	4.15
Change in Inventory	-	-	-265.95	-5.73	-11.87	8
Change in Accounts Payable	-	-	0.08	20.91	9.8	-1.96
Change in Other Net Operating Assets	-	-	-29.66	-24.29	5.18	-2.78
Operating Cash Flow	-	-	-395.4	2.4	-7.83	11.81
Capital Expenditures	-	-	-6.33	-0.14	-0.64	-5.33
Investment in Securities	-	-	-5.88	-	-	-
Investing Cash Flow	-	-	-12.21	-0.14	-0.64	-5.33
Short-Term Debt Issued	-	-	195.94	-	-	-
Long-Term Debt Issued	-	-	136.24	5.28	3.45	6.41
Total Debt Issued	-	-	332.19	5.28	3.45	6.41
Short-Term Debt Repaid	-	-	-	-1.69	-5.99	-1.03
Total Debt Repaid	-	-	-	-1.69	-5.99	-1.03
Net Debt Issued (Repaid)	-	-	332.19	3.59	-2.54	5.37
Issuance of Common Stock	-	-	84.44	2.29	15.82	-
Repurchase of Common Stock	-	-	-2.66	-	-	-10.99
Other Financing Activities	-	-	-9.3	-7.42	-6.62	-2.9
Financing Cash Flow	-	-	404.67	-1.54	6.66	-8.51
Miscellaneous Cash Flow Adjustments	-	-	4.67	-0	-0	-
Net Cash Flow	-	-	1.73	0.72	-1.82	-2.03
Free Cash Flow	-	-	-401.73	2.26	-8.47	6.48
Free Cash Flow Margin	-	-	-121.21%	0.61%	-2.99%	5.54%
Free Cash Flow Per Share	-	-	-70.92	0.46	-1.72	1.32
Cash Interest Paid	-	-	8.45	6.55	6.45	1.75
Cash Income Tax Paid	-	-	-	0.76	0.3	0.04
Levered Free Cash Flow	-	-	-412.64	-4.74	-14.88	-
Unlevered Free Cash Flow	-	-	-407.35	-0.65	-10.85	-
Change in Net Working Capital	159.58	165.69	415.57	9.62	16.69	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.